Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Immunogenicity of Sarilumab Monotherapy in Patients with Rheumatoid Arthritis Who Were Inadequate Responders or Intolerant to Disease-Modifying Antirheumatic Drugs.

Wells AF, Parrino J, Mangan EK, Paccaly A, Lin Y, Xu C, Fan C, Graham NMH, van Hoogstraten H, Torri A.

Rheumatol Ther. 2019 Sep;6(3):339-352. doi: 10.1007/s40744-019-0157-3. Epub 2019 May 14.

2.

Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis.

Strand V, Gossec L, Proudfoot CWJ, Chen CI, Reaney M, Guillonneau S, Kimura T, van Adelsberg J, Lin Y, Mangan EK, van Hoogstraten H, Burmester GR.

Arthritis Res Ther. 2018 Jun 19;20(1):129. doi: 10.1186/s13075-018-1614-z.

3.

Two years of sarilumab in patients with rheumatoid arthritis and an inadequate response to MTX: safety, efficacy and radiographic outcomes.

Genovese MC, van Adelsberg J, Fan C, Graham NMH, van Hoogstraten H, Parrino J, Mangan EK, Spindler A, Huizinga TWJ, van der Heijde D; EXTEND study investigators.

Rheumatology (Oxford). 2018 Aug 1;57(8):1423-1431. doi: 10.1093/rheumatology/key121.

4.

Fesoterodine for the Treatment of Nocturnal Urgency in Patients with Overactive Bladder Syndrome: An Analysis of Responders and Nonresponders.

Khusid JA, Weiss JP, Carlsson MO, Mangan EK.

J Urol. 2017 Nov;198(5):1119-1123. doi: 10.1016/j.juro.2017.04.098. Epub 2017 May 4.

PMID:
28479240
5.

Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, double-blind, parallel-group phase III trial.

Burmester GR, Lin Y, Patel R, van Adelsberg J, Mangan EK, Graham NM, van Hoogstraten H, Bauer D, Ignacio Vargas J, Lee EB.

Ann Rheum Dis. 2017 May;76(5):840-847. doi: 10.1136/annrheumdis-2016-210310. Epub 2016 Nov 17.

6.

The unique cytoplasmic domain of human FcγRIIIA regulates receptor-mediated function.

Li X, Baskin JG, Mangan EK, Su K, Gibson AW, Ji C, Edberg JC, Kimberly RP.

J Immunol. 2012 Nov 1;189(9):4284-94. doi: 10.4049/jimmunol.1200704. Epub 2012 Sep 28.

7.

C-reactive protein binding to FcgammaRIIa on human monocytes and neutrophils is allele-specific.

Stein MP, Edberg JC, Kimberly RP, Mangan EK, Bharadwaj D, Mold C, Du Clos TW.

J Clin Invest. 2000 Feb;105(3):369-76.

8.

FlbT couples flagellum assembly to gene expression in Caulobacter crescentus.

Mangan EK, Malakooti J, Caballero A, Anderson P, Ely B, Gober JW.

J Bacteriol. 1999 Oct;181(19):6160-70.

9.
11.

Supplemental Content

Loading ...
Support Center